SEER Stock Analysis: Buy, Sell, or Hold?
SEER - Seer, Inc. Class A Common Stock
$1.75
-0.02 (-1.13%)
▼
5d:
-6.91%
30d:
-10.71%
90d:
-8.85%
HOLD
LOW Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: May 13, 2026
0d
Smart Money Accumulation
SEER is down 5.6% this week, but smart money is accumulating calls. Top strike: $2.5 2026-07-17 with 317 OI. Call ratio: 100% View Scanner →
Strength: 7.8/10
Get Alerted When SEER Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SEER shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: SEER shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: SEER is currently trading at $1.75, which is considered oversold relative to its 30-day fair value range of $1.77 to $1.99.
Technical Outlook: Technically, SEER is showing sideways momentum. The price is currently testing key support at $1.73. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $4.00 (+128.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SEER is showing sideways momentum. The price is currently testing key support at $1.73. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $4.00 (+128.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.77 -
$1.99
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 128.6% below Wall St target ($4.00)
- CAUTION: Recommendation downgraded due to -6.9% 5-day decline
Trading Range Analysis
30-Day Trading Range
$1.77 -
$1.99
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.73
Resistance Level
$2.09
Current Trend
Sideways
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.61
Wall Street Target
$4.00
(+128.6%)
Revenue Growth (YoY)
5.0%
Share & Embed Analysis
Last updated: May 14, 2026 8:16 PM ET
Data refreshes hourly during market hours. Next update: 9:16 PM
Data refreshes hourly during market hours. Next update: 9:16 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SEER showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
David R Horn
SELL
6797 shares
2025-11-19
Omid Farokhzad
SELL
33838 shares
2025-11-19
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$550 | 64 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$875 | 63 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 60 BUY |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$242 | 61 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 51 HOLD |
